GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Other Current Liabilities

NewAmsterdam Pharma Co NV (FRA:KH6) Other Current Liabilities : €14.63 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Other Current Liabilities?

NewAmsterdam Pharma Co NV's other current liabilities for the quarter that ended in Dec. 2023 was €14.63 Mil.

NewAmsterdam Pharma Co NV's quarterly other current liabilities increased from Dec. 2022 (€5.80 Mil) to Jun. 2023 (€7.75 Mil) and increased from Jun. 2023 (€7.75 Mil) to Dec. 2023 (€14.63 Mil).

NewAmsterdam Pharma Co NV's annual other current liabilities increased from Dec. 2021 (€0.46 Mil) to Dec. 2022 (€5.80 Mil) and increased from Dec. 2022 (€5.80 Mil) to Dec. 2023 (€14.63 Mil).


NewAmsterdam Pharma Co NV Other Current Liabilities Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Other Current Liabilities Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - -

NewAmsterdam Pharma Co NV Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial - - - - -

NewAmsterdam Pharma Co NV Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


NewAmsterdam Pharma Co NV Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Traded in Other Exchanges
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines